Friends of the Liver - The Challenge of Hepatitis C in Central and South Eastern Europe

By EASL EU Public Affairs April 07,2017

The MEP Friends of the Liver group held a meeting in the European Parliament on March 22nd 2017.

The focus of the meeting was on the burden of Hepatitis C in the Baltic and Central and South Eastern EU member states. Speakers from the European Parliament, the European Commission the European Monitoring Centre for Drugs and Drug Addiction, patients groups and hepatology community presented and discussed the situation and the steps needed to get better access to treatment for HCV patients in the region. 

 

Download the presentations from the Friends of the Liver event.

The 2016 ELPA Hep-CORE Report - European Liver Patients Association

Risk and prevention of drug-related infections in the Baltic and South Eastern EU member states - focus on HCV - Dagmar Hedrich EMCDDA

The EASL HCV treatment guidelines: Who should be treated and when - Prof Helena Cortez-Pinto, EASL EU Policy Councillor

HCV Romanian framework - Prof Adrian Streinu-Cercel MD, PhD, HC

Are patients getting the treatment they need in Poland? - Dr hab.med. Jerzy Jaroszewicz, Vice-President of the Polish Society for the Study of the Liver

HCV infection in Bulgaria -Marieta Simonova, MD

The burden of Hepatitis C in Lithuania and the gaps in screening and treatment. Development of Lithuanian National Hepatitis C strategy - Prof Ligita Jančorienė MD, PhD

Hepatitis C Disease Burden and Strategies to Minimize its Consequences in the Future - Assumptions and outputs for Romania - Dr Corina Pop

Hepatitis C: Policy in Action - Ricardo Baptista Leite MP, MD, PhD(C)